Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Stephanie Okey Sells 17,500 Shares

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) Director Stephanie Okey sold 17,500 shares of Crinetics Pharmaceuticals stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $46.38, for a total value of $811,650.00. Following the completion of the sale, the director now owns 6,000 shares of the […]

Related Keywords

China ,Robertw Baird ,Stephanie Okey ,Morgan Stanley ,China Universal Asset Management Co ,Osaic Holdings Inc ,Cantor Fitzgerald ,News Ratings For Crinetics Pharmaceuticals Daily ,Crinetics Pharmaceuticals Company Profile ,Quarter For Crinetics Pharmaceuticals ,Nasdaq ,Tower Research Capital ,Crinetics Pharmaceuticals ,Crinetics Pharmaceuticals Stock Performance ,Crinetics Pharmaceuticals Inc ,Hedge Funds Weigh In On Crinetics Pharmaceuticals ,Get Free Report ,Director Stephanie Okey ,Research Capital ,Universal Asset Management ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,